RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cambridge Cognition Holdings Stock

Cambridge Cognition Holdings P/E 2024

Cambridge Cognition Holdings P/E

-23.24

Ticker

COG.L

ISIN

GB00B8DV9647

WKN

A1T9LW

As of Aug 31, 2024, Cambridge Cognition Holdings's P/E ratio was -23.24, a 135.7% change from the -9.86 P/E ratio recorded in the previous year.

The Cambridge Cognition Holdings P/E history

Cambridge Cognition Holdings Aktienanalyse

What does Cambridge Cognition Holdings do?

Cambridge Cognition Holdings PLC is a British company specializing in the development of computer programs for cognitive assessment of patients in medical research and development. The company was founded in 1986 by a group of neuroscientists from the University of Cambridge, who aimed to conduct neuropsychological research in standardized and automated form. The development of tests that could be conducted on computers was intended to increase the accuracy and efficiency of neuropsychological assessment of patients. The business quickly grew into a successful company, and Cambridge Cognition Holdings PLC was listed on the London Stock Exchange in 2013. The core business of the company is to provide tests and tools for assessing the cognitive functions of patients in medical research and development. Cambridge Cognition's products and services can be divided into two main categories: cognitive tests and digital therapeutic interventions. Cambridge Cognition's cognitive tests include a variety of specialized tests designed to assess the cognitive functions of patients. These tests cover areas such as memory, attention, executive function, and fine motor skills. The tests can be conducted on desktop computers, tablets, or mobile devices, offering standardization, efficiency, and reproducibility in the assessment of patients' cognitive functions. Another branch of the company is the development of digital therapeutic interventions. These interventions are designed to improve or maintain the cognitive functions of patients by triggering specific brain activities. An example of this is the "CogniFit" program for improving the cognitive abilities of older people. By using computer-based tests, the program aims to enhance users' cognitive functions and help slow down cognitive decline in old age. Cambridge Cognition Holdings PLC is not only involved in medical research but also in the pharmaceutical industry. The company offers services to pharmaceutical companies for conducting clinical studies testing the effectiveness of new drugs on cognitive functions. The combination of Cambridge Cognition's cognitive tests with clinical research provides an accurate assessment of the impact of medications on patients' cognitive functions. Cambridge Cognition's business model is based on the development and marketing of cognitive tests and digital therapeutic interventions. The company collaborates with medical research and development departments of pharmaceutical companies, academic institutions, and clinics. It also provides services related to clinical research to evaluate the effectiveness of new drugs on cognitive functions. Overall, Cambridge Cognition Holdings PLC is a leading company in medical research and development. Through the development of cognitive tests and digital therapeutic interventions, the company can contribute to improving patients' cognitive functions and accelerate the development of new medical therapies. Cambridge Cognition Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Cambridge Cognition Holdings's P/E Ratio

The Price to Earnings (P/E) Ratio of Cambridge Cognition Holdings is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Cambridge Cognition Holdings's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Cambridge Cognition Holdings is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Cambridge Cognition Holdings’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Cambridge Cognition Holdings stock

What is the price-to-earnings ratio of Cambridge Cognition Holdings?

The price-earnings ratio of Cambridge Cognition Holdings is currently -23.24.

How has the price-earnings ratio of Cambridge Cognition Holdings changed compared to last year?

The price-to-earnings ratio of Cambridge Cognition Holdings has increased by 135.7% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Cambridge Cognition Holdings high compared to other companies?

Yes, the price-to-earnings ratio of Cambridge Cognition Holdings is high compared to other companies.

How does an increase in the price-earnings ratio of Cambridge Cognition Holdings affect the company?

An increase in the price-earnings ratio of Cambridge Cognition Holdings would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Cambridge Cognition Holdings affect the company?

A decrease in the price-earnings ratio of Cambridge Cognition Holdings would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Cambridge Cognition Holdings?

Some factors that influence the price-earnings ratio of Cambridge Cognition Holdings are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Cambridge Cognition Holdings pay?

Over the past 12 months, Cambridge Cognition Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cambridge Cognition Holdings is expected to pay a dividend of 0 GBP.

What is the dividend yield of Cambridge Cognition Holdings?

The current dividend yield of Cambridge Cognition Holdings is .

When does Cambridge Cognition Holdings pay dividends?

Cambridge Cognition Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cambridge Cognition Holdings?

Cambridge Cognition Holdings paid dividends every year for the past 0 years.

What is the dividend of Cambridge Cognition Holdings?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cambridge Cognition Holdings located?

Cambridge Cognition Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cambridge Cognition Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cambridge Cognition Holdings from 8/31/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 8/31/2024.

When did Cambridge Cognition Holdings pay the last dividend?

The last dividend was paid out on 8/31/2024.

What was the dividend of Cambridge Cognition Holdings in the year 2023?

In the year 2023, Cambridge Cognition Holdings distributed 0 GBP as dividends.

In which currency does Cambridge Cognition Holdings pay out the dividend?

The dividends of Cambridge Cognition Holdings are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cambridge Cognition Holdings

Our stock analysis for Cambridge Cognition Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cambridge Cognition Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.